Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients

The severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2) Omicron variant (B.1.1.529) is spreading rapidly, even in vaccinated individuals, raising concerns about immune escape. Here, we studied neutralizing antibodies and T-cell responses targeting SARS-CoV-2 D614G (wildtype, WT), a...

Descripción completa

Detalles Bibliográficos
Autores principales: GeurtsvanKessel, Corine H., Geers, Daryl, Schmitz, Katharina S., Mykytyn, Anna Z., Lamers, Mart M, Bogers, Susanne, Scherbeijn, Sandra, Gommers, Lennert, Sablerolles, Roos S.G., Nieuwkoop, Nella N., Rijsbergen, Laurine C., van Dijk, Laura L.A., de Wilde, Janet, Alblas, Kimberley, Breugem, Tim I., Rijnders, Bart J.A., de Jager, Herbert, Weiskopf, Daniela, van der Kuy, P. Hugo M., Sette, Alessandro, Koopmans, Marion P.G., Grifoni, Alba, Haagmans, Bart L., de Vries, Rory D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939771/
https://www.ncbi.nlm.nih.gov/pubmed/35113647
http://dx.doi.org/10.1126/sciimmunol.abo2202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939771/
https://www.ncbi.nlm.nih.gov/pubmed/35113647
http://dx.doi.org/10.1126/sciimmunol.abo2202

Ejemplares similares